Citation: | CHEN Jin-qiang, LI Chun-da, LI Fu-qiang, LU Li-ming, FANG Bin, JIN Zhi-hua. Analysis and treatment of the risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(7): 1131-1134. doi: 10.16766/j.cnki.issn.1674-4152.002003 |
[1] |
朱龙川, 甘达凯, 胡青青, 等. 第三代头孢菌素耐药的自发性细菌性腹膜炎发生的预测因素[J]. 临床肝胆病杂志, 2019, 35(7): 1501-1504. doi: 10.3969/j.issn.1001-5256.2019.07.016
|
[2] |
李佩波, 秦凡博, 龚建平. 肝硬化患者肠道屏障与细菌易位的关系[J]. 临床肝胆病杂志, 2019, 35(8): 1854-1857. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201908060.htm
|
[3] |
吴莹雯, 张桂灵, 姜宏伟, 等. 哌拉西林舒巴坦治疗肝硬化患者自发性细菌性腹膜炎的临床观察[J]. 中国现代医生, 2019, 57(21): 24-27. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201921008.htm
|
[4] |
孟樱, 骆欣, 赵国根, 等. 乙肝肝硬化合并自发性细菌性腹膜炎患者血清和腹水中糖链抗原125及降钙素原的变化情况[J]. 中华全科医学, 2017, 15(7): 1239-1241. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201707046.htm
|
[5] |
彭官清, 凌乔, 潘沛沛, 等. 肝硬化并发自发性细菌性腹膜炎患者血清中颗粒蛋白前体水平及临床意义[J]. 中华医院感染学杂志, 2019, 29(23): 3558-3562. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201923011.htm
|
[6] |
OIKONOMOU T, PAPATHEODORIDIS G V, SAMARKOS M, et al. Clinical impact of microbiome in patients with decompensated cirrhosis[J]. World J Gastroentero, 2018, 24(34): 3813-3820. doi: 10.3748/wjg.v24.i34.3813
|
[7] |
YAN D, HUANG Y D, CHEN Y B, et al. Risk factors for Clostridium difficile infection in cirrhotic patients[J]. Hepatobiliary Pancreat Dis Int, 2019, 18(3): 237-241. doi: 10.1016/j.hbpd.2019.04.003
|
[8] |
周鹏. 肝硬化患者血清miR-122的表达及与Child-Pugh分级的关系[J]. 中国老年学杂志, 2017, 37(15): 3802-3803. doi: 10.3969/j.issn.1005-9202.2017.15.071
|
[9] |
谭志洁, 赵静, 刘文兴, 等. 肝硬化腹水患者并发自发性细菌性腹膜炎病原菌与影响因素分析[J]. 中华医院感染学杂志, 2019, 29(19): 2953-2956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201919018.htm
|
[10] |
RIGHI E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions[J]. World J Gastroentero, 2018, 24(38): 4311-4329. doi: 10.3748/wjg.v24.i38.4311
|
[11] |
古川, 宋美怡, 孙文静, 等. 2016年肝硬化领域基础与临床研究进展[J]. 中华肝脏病杂志, 2017, 25(1): 5-8. doi: 10.3760/cma.j.issn.1007-3418.2017.01.003
|
[12] |
方亚平, 陈杏林, 刘文芳, 等. 肝硬化腹水合并自发性细菌性腹膜炎的病原学及危险因素分析[J]. 中华医院感染学杂志, 2017, 27(13): 2924-2927. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201713012.htm
|
[13] |
顾君娣, 陆佳敏, 江军, 等. 肝硬化腹水患者合并自发性细菌性腹膜炎病原菌及相关因素分析[J]. 中华医院感染学杂志, 2018, 28(19): 2940-2943. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201819016.htm
|
[14] |
周小兵, 李玉鑫, 高方媛, 等. 肝硬化合并自发性细菌性腹膜炎133例的危险因素分析[J]. 中华消化杂志, 2019, 39(4): 268-270. doi: 10.3760/cma.j.issn.0254-1432.2019.04.010
|
[15] |
熊克宫, 柯坤宇, 孔金峰, 等. 中性粒细胞CD64对自发性细菌性腹膜炎抗生素应用的指导价值[J]. 中国现代医学杂志, 2017, 27(19): 70-73. doi: 10.3969/j.issn.1005-8982.2017.19.014
|
[16] |
FIORE M, MARAOLO A E, GENTILE I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review[J]. World J Gastroentero, 2017, 23(25): 4654-4660. doi: 10.3748/wjg.v23.i25.4654
|
[17] |
HUANG C H, PANG L T, XU L C, et al. Risk factors, clinical features, and short-term prognosis of spontaneous fungal peritonitis in cirrhosis: A matched case-control study[J]. World J Clin Cases, 2019, 7(17): 2438-2449. doi: 10.12998/wjcc.v7.i17.2438
|
[18] |
曾婷, 曾凌, 曹先伟, 等. 耐碳青霉烯类铜绿假单胞菌耐药基因与药敏分析[J]. 中华医院感染学杂志, 2019, 29(20): 3063-3067. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201920006.htm
|
[19] |
孙殿静, 代晓茹, 刘晴晴, 等. 舒血宁联合哌拉西林/舒巴坦在2型糖尿病合并下呼吸道感染患者中的应用效果[J]. 中华医院感染学杂志, 2017, 27(10): 2229-2232. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201710018.htm
|